Malaria control and elimination requires a multifaceted approach. Right now we have a good set of tools, including insecticide sprays and long-lasting insecticide-treated mosquito nets that help prevent transmission by mosquitoes. But no prevention strategy is 100% effective - there will always be instances of network intrusion. The current WHO-recommended treatment for the majority of malaria cases is artemisinin-based combination therapy (ACT). These drugs, along with diagnostics, are available to treat and in some cases prevent malaria.
Malaria treatment depends on the type of malaria, as well as the severity of the disease. The World Health Organization's guidelines for treating malaria provide recommendations on topics such as:
* Uncomplicated treatment p. Falciparum malaria
* Treatment for uncomplicated malaria caused by p. Vivax
* Treating severe malaria
* Collective drug administration
* .... and more
Developing effective antimalarials to save lives:
The MMV portfolio focuses on providing effective, affordable, available and suitable medicines for use in malaria endemic areas. Specifically, the goal is to develop products that provide: efficacy against drug-resistant strains of P. falciparum, possibility of intermittent therapy (infants and pregnancy), safety in young children (<6 months), safety during pregnancy, and efficacy against P. That radical treatment), effectiveness against acute malaria, and treatment to prevent transmission.